Cancer is our SPECIALTY. Healing is our PASSION.
Integrated on-site cancer care options help streamline patient testing and facilitate the patient care cycle. Our efficient all-in-house services save patients time and resources while enabling us to easily keep you updated on your patient’s progress.
Each of our cancer centers is easily accessible and conveniently located close to home. Our relaxed, family-oriented environment and caring staff help put patients and their families at ease. We take pride in our patient satisfaction and quality of care. Our Staff includes physicians and support staff fluent in Spanish as well as several other languages.
We have simplified the patient referral process to save you time and to ensure we see your patient as quickly as possible. Our referral process is completed in two easy ways:
By Telephone - A well-trained Medical Representative will be there to meet your needs. You can find the appropriate number on our locations list.
- By Fax - Complete our referral form and fax it to the office of your choice. Within 24 hours, we will contact your staff to advise you of the date and time of your patient’s scheduled appointment. View locations list.
If you need more information about our clinical trials program or if you have a patient who might meet eligibility requirements for a specific research study, please see our Clinical Research & Trials section.
Cancer in the News
- Colorectal cancer: Results of Heidelberg Pharma's research cooperation with MD Anderson Cancer Center published
- Sex, disease resistance linked to elite aging in study of oldest-living dogs
- Standard clinical assays can obscure the diversity of breast cancer subtypes
- New guidelines recommend women with rare aggressive breast cancer should be offered less invasive surgery
- Predictive genetic markers associated with breast cancer neuropathy identified
- Mortality risks of cigar smoking similar to that of cigarette smoking
- Brain tumor growth stimulated by nerve activity in the cortex, Stanford study finds
- Eligible for breast conserving therapy, many still choose mastectomy
- Toxic mushroom-based drug may help battle colorectal cancer
- Form of permanent radiotherapy may prolong prostate cancer suvival, study finds
- Study illuminates role of cancer drug decitabine in repairing damaged cells
- New therapeutic target for a type of colorectal cancer with poor prognosis has been identified
- Global Hepatitis B epidemic can be treated for $36 (£24) per person per year
- Ovary removal linked with 62% reduction in BRCA1-related breast cancer deaths